Harmony Biosciences Holdings (HRMY) Debt Ratio (2019 - 2026)

Harmony Biosciences Holdings (HRMY) has 8 years of Debt Ratio data on file, last reported at 0.12 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 24.97% year-over-year to 0.12; the trailing twelve-month figure through Mar 2026 stood at 0.12 (down 24.97% YoY), and the FY2025 full-year result was 0.13, down 28.26% from the prior year.
• Debt Ratio retreated to 0.12 in Q1 2026, from 0.13 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.41 in Q1 2022 to a low of 0.12 in Q1 2026.
• A 5-year average of 0.23 and a median of 0.22 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio plunged 39.33% in 2022 and fell 13.78% in 2024, its largest moves.
• Tracing HRMY's Debt Ratio over 5 years: stood at 0.28 in 2022, then dropped by 16.12% to 0.24 in 2023, then declined by 24.79% to 0.18 in 2024, then slipped by 28.26% to 0.13 in 2025, then fell by 2.98% to 0.12 in 2026.
• Business Quant data shows HRMY's Debt Ratio at 0.12 in Q1 2026, 0.13 in Q4 2025, and 0.14 in Q3 2025.